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Aortofemoral graft limb–to–colon paraprosthetic fistula
Luis R. Leon, Jr, MD, RVT,a,b Shemuel B. Psalms, BSHS,a Daniel M. Ihnat, MD,a,b andJoseph L. Mills, Sr, MD,a,b Tucson, ArizA 58-year-old man presented with fever. During several hospitalizations in the
preceding 3 months, bacteremia had been documented on seven occasions.
Escherichia coli, Clostridium, and Candida spp were repeatedly recovered in blood
cultures. The patient’s history was pertinent for tobacco abuse and severe claudi-
cation, which was initially treated with femorofemoral bypass graft. This failed,
however, which prompted conversion to an aortobifemoral bypass (performed
elsewhere), with resultant complete relief of claudication. The patient denied
abdominal pain and had no evidence of overt or occult gastrointestinal (GI)
bleeding.
Fever and malaise persisted for 3 months. Abdominal computed tomography
(CT) scans were performed on two occasions, and the results interpreted as
negative. The Vascular Surgery Service was ultimately consulted and determined
the patient’s clinical history and CT were highly suggestive of a secondary aortoen-
teric fistula (SAEF) involving the left aortobifemoral graft limb and the colon (A,
arrow). The graft body, right limb, and both femoral regions appeared to be free of
infection. An indium-111 white blood cell scan suggested isolated left midpros-
thetic limb involvement (B, arrow), and colonoscopy unequivocally established the
diagnosis (Cover).
Single-stage redo femorofemoral bypass and left aortofemoral graft limb
excision was performed. At laparotomy, the left graft limb was densely incorpo-
rated to adjacent tissues, without gross contamination. The limb was transected
and oversewn proximally. When followed distally, it was noted to traverse the
sigmoid colon (C). Partial sigmoid resection with primary anastomosis was per-
formed. The patient has since done well, without evidence of recurrent infection
and with patent vascular reconstructions.
SAEF is a direct communication between a vascular prosthesis and the GI
tract. Most aortoenteric fistulas involve the graft-aortic suture line, with fistuliza-
tion into the bowel lumen and resultant GI hemorrhage. A less common type of
fistula, termed a paraprosthetic fistula, is defined as a communication between the
surface of the graft body and the bowel lumen without suture line involvement or
actual fistulization into the vascular lumen.1
The duodenum is the most frequently involved bowel segment for both types
of SAEFs. Graft-colonic fistulae are much less common, comprising only 4.8% to
6.6% of cases in reported SAEF series.1,2 Because they do not involve the anasto-
mosis, paraprosthetic fistulas do not result in GI hemorrhage, but rather sepsis,
malaise, and other less specific symptoms. In patients who do not require emer-
gency intervention, CT is the recommended initial diagnostic study of choice
whenever SAEF is considered. A positive indium-111 white blood cell scan
supports the diagnosis of SAEF. Endoscopy can be a definitive diagnostic tool, but
may also serve to exclude other pathology in patients with GI bleeding.
Traditional therapy for SAEF, especially for aortoduodenal fistula, is GI tract
restoration, complete prosthetic graft excision, aortic stump closure, and extra-ana-
tomic bypass. More conservative approaches such as partial graft preservation, excision
of the involved limb, and extra-anatomic bypass, as used in this patient, are simpler,
effective, and have potentially less morbidity in carefully selected, high-risk patients.
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